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trkC receptors, which serve critical functions during the development of the nervous system, are alternatively spliced
to yield isoforms containing the catalytic tyrosine kinase domain (TK1) and truncated isoforms which lack this
domain (TK2). To test for potential differences in their roles during early stages of neural development, TK1 and TK2
isoforms were ectopically expressed in cultures of neural crest, the stem cell population that gives rise to the vast
majority of the peripheral nervous system. NT-3 activation of ectopically expressed trkC TK1 receptors promoted both
proliferation of neural crest cells and neuronal differentiation. Strikingly, the trkC TK2 isoform was significantly more
effective at promoting neuronal differentiation, but had no effect on proliferation. Furthermore, the trkC TK2 response
was dependent on a conserved receptor cytoplasmic domain and required the participation of the p75NTR neurotrophin
receptor. Antibody-mediated receptor dimerization of TK1 receptors, but not TK2 receptors, was sufficient to
stimulate differentiation. These data identify a phenotypic response to activation of the trkC TK2 receptor and
demonstrate a functional interaction with p75NTR, indicating there may be multiple trkC receptor-mediated systems
guiding neuronal differentiation. © 1998 Academic Press
INTRODUCTION
Neurotrophin-3 has been shown to regulate multiple
events in the development of the peripheral nervous sys-
tem, including the survival and proliferation of neural
precursor cells, neural differentiation, and neuronal sur-
vival (cf. Davies, l994; Lewin and Barde, l996). trkC, the
primary high-affinity receptor for NT-3, has been shown to
be expressed throughout neurogenesis and neuronal differ-
entiation in the peripheral nervous system (Tessarollo et
al., l993; Zhang et al., l994; Williams et al., l993; Henion et
al., l995; Lefcort et al., l996), yet an analysis of its function
has been complicated by the existence of multiple receptor
splice forms. In addition to the canonical tyrosine kinase-
containing isoform, other isoforms have been identified
which contain inserts, or entirely lack the catalytic kinase
domain (the “truncated” or TK2 isoform) or are missing the
last third of the kinase domain (Tsoulfas et al., l993;
Valenzuela et al., l993; Garner and Large, l994). The trkB
gene, the BDNF high-affinity receptor, but not trkA, also
codes for splice forms which are truncated, or lack the
kinase domain (Klein et al., l990; Middlemass et al., l991).
In both trkB and trkC, an alternative cytoplasmic domain
which is not present in the TK1 splice form is substituted
for the kinase domain. While the trkB and trkC alternative
cytoplasmic domains differ from each other, they are each
highly conserved across species (Garner and Large, l994;
Biffo et al., l995; Armanini et al., l995).
To date, no independent functions have been identified for
the kinase deleted isoforms. Rather, they have been assumed
to only modulate the activity of the tyrosine kinase isoforms
of trk receptors, including sequestering or presenting neuro-
trophin to TK1 receptors or to act as potential dominant
negatives to dampen signaling through the TK1 receptor
isoforms. Recent intriguing data from Tessarolo, Parada, and
their colleagues have shown that targeted deletion in mice of
the entire trkC gene results in a more severe phenotype than
does elimination of just the kinase-containing isoform of trkC
(Klein et al., l994; Donovan et al., l996; Tessarollo et al., l997),
suggesting that the truncated isoform of the receptor does play
a significant role in vivo.
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To directly determine the function of distinct isoforms of
trkC, we ectopically expressed individual trkC isoforms in
neural crest cells, since they are the stem cell population
that gives rise to the vast majority of the peripheral nervous
system. Several growth factors have been demonstrated to
influence neural crest cell behavior (cf Stemple and Ander-
son, l993) including NT-3 (Pinco et al., l993; Kalcheim et
al., l992; Henion et al., l995) although the NT-3 receptors
which transduce these activities have not been completely
identified. Our data demonstrate that activation of ectopi-
cally expressed kinase-containing trkC receptors induces
both the proliferation and neural differentiation of neural
crest cells, while activation of the truncated, kinase-deleted
trkC receptor has no effect on cell proliferation but strik-
ingly induces neural differentiation. Furthermore, we show
that this activity mediated by the TK2 trkC receptor
requires the participation of p75NTR.
METHODS
Avian Neural Crest Cultures
Neural tubes were dissected from White Leghorn chickens
between Stages 12 and 17 and cultured for up to 24 h as described
(Sieber-Blum, l991). Neural tubes were then removed, and neural
crest cells were replated in 8-well Nunc or Falcon glass chamber
slides that were coated with fibronectin (50 mg/ml; Gibco). Equal
numbers of cells were plated in each well and all experimental
conditions were repeated in quadruplicate. Immediately following
replating, RCASBP virus, either control or engineered to contain
trkC receptor isoforms, was added to each well at a concentration
titered to infect at least 90% of the crest cells. NT-3 (rHu,
Peprotech, 20–40 ng/ml) was added either at the time of virus
application or 24 h later. The total number of cells in each well was
determined 2–4 h after plating (t 5 0) and again at 24 and 48 h by
phase-contrast microscopy. Forty-eight hours after exposure to
virus, all cells were fixed in 4% paraformaldehyde and stained with
a nuclear stain, DAPI (Molecular Probes) and with an antibody
(CTC IgG) to the extracellular domain of avian trkC (Lefcort et al.,
l996), and an antibody to the 180-kDa neurofilament subunit (kind
gift of Dr. B. Granger, Montana State University), and/or p19GAG
(AMV-3C2, Developmental Studies Hybridoma Bank) followed by
labeling with fluorescently tagged secondary antibodies (Jackson
Immunoresearch Labs). To visualize p75 NTR and to block p75
activity, we used the anti-avian p75 antibody, CHEX (Weskamp
and Reichardt, l991; kind gift of Dr. L. F. Reichardt). To verify cell
surface expression of ectopically expressed trkC, infected, cultured
neural crest cells were washed and labeled for 1 h at 4°C with the
CTC IgG. Cells were then washed and fixed in 4% paraformalde-
hyde and labeled for 1 h with secondary antibodies as described. As
a control, in some wells, the primary antibody was excluded. To
quantify the extent of neuronal differentiation in each culture, the
percentage of neurofilament-positive cells of 200–500 cells/well
was determined. NF1 cells with a small round or oval phase-bright
cell body and long thin neurites were counted as neurons, while
larger flattened lamellar NF1 cells with thick, short neurites were
counted as “proneurons.” In each experiment, all conditions were
carried out in quadruplicate and statistical significance was deter-
mined by ANOVA and Student–Newman–Keuls method. We noted
that in initial experiments, total cell number after 48 h increased
under all culture and virus conditions, with the greatest increase in
wells infected with the TK1 virus. However, cell numbers in later
experiments tended to decrease for all conditions, except for the
TK1-infected cultures. This may be due to undefined changes in
serum lots or embryo extracts, but did not affect the results since
the relative differences among TK1, TK2, Cyto2, or KT-infected
cells compared to each other and to control virus-infected cells was
constant throughout the study. To determine the labeling index
(LI), the percentage of BrdU-positive cells in each well was deter-
mined. BrdU (10 mg/ml; Sigma) was added at t 5 24 h and cells were
fixed 18 h later. BrdU1 cells were detected by immunocytochem-
istry with an anti-BrdU antibody per instructions (Novocastra).
Retroviral Expression of trkC Isoforms
Isolation of the trkC TK1, KT, and TK2 cDNAs were described
previously (Garner and Large, l994). The TK2 cDNA, which
contains most of the cytoplasmic juxtamembrane domain and a
conserved 39 amino acid C-tail, was engineered to include the T
antigen epitope tag by fusing the sequence WWSSKPPTPPPEPET to
the C-terminus. The Cyto2 construct was engineered to remove all
but the first two amino acids of the TK2 cytoplasmic sequence and
retaining the C-terminal epitope tag. The cDNAs encoding the
trkC receptor isoforms were subcloned into the replication com-
petent avian retrovirus RCASBP(B) (Hughes et al., l987) and propa-
gated in line 0 pathogen-free chick embryo fibroblasts (CEF) as
previously described (Garner and Large, l994).
Immunoblots and Immunoprecipitates
Cell lysates were prepared from infected chick embryo fibro-
blasts (Garner and Large, l994) and incubated with the CTC trkC
IgG (Lefcort et al., l996) overnight at 4°C. After reduction, immu-
noprecipitated proteins were run on an SDS gel, transferred onto
polyvinyl difluoride membrane (Sigma), followed by sequential
incubation in CTC trkC IgG, protein A–HRP (Amersham), and
developed with chemiluminescence detection (Amersham).
RT/PCR of trkC mRNA
Total RNA from embryonic DRG was isolated using RNAzolB
(Tel-Test, Inc.) and the reverse transcription and PCR amplification
were as described in the GeneAmp RNA PCR kit (Perkin–Elmer
Cetus). Specific pairs of 24-mer primers were used to amplify
mRNA for trkC TK1 isoforms (Garner and Large, l), trkC TK2
(forward, ACAAGGGGAAGTGTCTGA; and reverse, GCTGAA-
ATAAACACTGACATCCTC) and b-actin. An annealing tempera-
ture of 58°C and 30 cycles was used for all three reactions, a
number empirically determined to be within the linear phase of
amplification of trkC transcripts (Garner and Large, unpublished
data). The reactions were separated on a 1.5% agarose gel, dena-
tured, and transferred to Genescreen Plus (NEN, DuPont) and
hybridized with internal 32P-labeled cRNA and oligonucleotide
probes specific for each product.
RESULTS
Avian neural crest cells were infected in vitro with
RCAS(BP) retrovirus engineered to express either full-
length receptors (TK1), or the kinase-truncated (KT) and
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kinase-minus (TK2) isoforms lacking kinase activity (Fig.
1). Immunoblots with an anti-trkC antibody (CTC IgG;
Lefcort et al., l996) confirmed expression of each receptor
isoform (Fig. 2A). Within 24 h of infection, between 90 and
100% of the cells expressed the p19GAG viral protein and,
except for cells infected with control virus, were strongly
immunopositive for trkC (Figs. 2B and 3). In permeabilized,
fixed cells, approximately 60% of the uninfected and con-
trol virus infected cells were very faintly trkC immunopo-
sitive. However, the level of this putative endogenous trkC
expression was considerably weaker than that observed in
cells infected with the trkC-containing viruses (compare
Fig. 2B, a and b to c and d; and compare Fig. 3A to 3B and
3C). These data demonstrate the effectiveness of RCAS-
mediated expression in neural crest cells in vitro and that
all viral constructs could drive expression of their respec-
tive trk isoform.
To determine whether the trkC immunoreactivity ob-
served corresponded to cell surface expression, we immu-
nolabeled virus-infected, nonpermeabilized, live, cultured
neural crest cells at 4°C with the anti-trkC antibody (Fig. 3).
This procedure not only confirmed that the TK2 and TK1
ectopically expressed trkC receptor was on the cell surface,
but also that no trkC immunoreactivity was evident on
control virus-infected cells. Thus we conclude that the faint
trkC immunoreactivity observed on fixed, permeablized,
control virus-infected cells (Fig. 2) reflects either low levels
of cytoplasmically localized, and hence unavailable recep-
tor, or background immunoreactivity which can often ap-
pear in triton-permeablized, fixed cells.
Since trk receptors can regulate mitosis (cf. Bothwell,
l995), we determined whether activation of trkC would
influence neural crest cell proliferation (Fig. 4A). In the
absence of ligand (NT-3) activation, there were no signifi-
cant differences in cell number between any of the virus
treatments (data not shown). In the presence of NT-3,
cultures expressing TK1 receptors contained about 20%
more cells (P # 0.0001) than control virus-infected cells. In
contrast, cultures expressing TK2 or KT trkC isoforms
showed no significant difference in cell number from con-
trol cultures. To determine whether the trkC TK1-induced
increase was due to enhanced mitotic activity, we mea-
sured the labeling index. Cultures expressing TK1 recep-
tors contained significantly more BrdU1 cells than all other
conditions and had a significantly higher LI (Table 1). The
fact that there were consistently (n 5 16 separate experi-
FIG. 1. Four isoforms of the avian trkC receptor, differing in their
cytoplasmic domains, were expressed using RCAS(BP) retrovirus.
TK1 indicates full-length trkC receptors containing the tyrosine
kinase domain (large open box). KT indicates a naturally occurring
trkC splice variant that replaces the last two-thirds of the kinase
domain with novel sequence (speckled box) and lacks kinase
activity (“kinase-truncated”: Garner and Large, l994). TK2 indi-
cates a splice variant that replaces the tyrosine kinase domain with
a 39-amino-acid domain (hatched box), essentially identical to that
found in mammalian trkC TK2 isoforms. The black circle repre-
sents a 13-amino-acid SV40 T antigen epitope tag. Cyto2 indicates
a mutated trkC receptor that retains only the first 2 amino acids of
the cytoplasmic domain fused to the epitope tag.
FIG. 2. (A) Retroviral-mediated expression of trkC isoforms. Ex-
tracts from chick embryo fibroblasts infected with either control,
TK1, TK2, KT, or Cyto2 RCAS viruses were immunoprecipitated
with CTC IgG. Immunoprecipitates were reduced and separated on
an SDS gel, transferred to PVDF membrane, and immunoblotted
with the CTC IgG. The lower-molecular-weight band visible in the
TK1 lane is the precursor, underglycosylated form of the full-
length trkC protein (Garner and Large, l994). (B) Recombinant
RCAS retroviruses effectively infect chicken neural crest cells in
vitro and can drive the expression of trkC. Cultured neural crest
cells were fixed and permeabilized and then immunolabeled either
with the CTC IgG (a–d) or the anti- p19GAG antibody (e–h). For
detection of trkC expression, all photographic exposure times were
of equal duration to compare relative levels of expression. A subset
of uninfected cells (a, e) are weakly trkC immunoreactive and
exhibit only background staining for p19GAG. Control virus-
infected cells (b, f) are equally weakly trkC immunoreactive but are
brightly labeled with the p19GAG antibody. Both the TK1-infected
(c, g) and TK2-infected (d, h) cells are strongly positive for trkC and
for p19GAG. (Scale bar, 75 mm). In this figure, cells were not double
labeled with both antibodies simultaneously to prevent the strong
anti-GAG immunoreactivity from spilling through the filter chan-
nel used to observe the anti-trkC labeling.
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ments) more cells at t 5 48 h than at t 5 0 is further
evidence that activation of the TK1 receptor promotes
proliferation in these early cultures.
Previous studies have shown that NT-3 can regulate
neural crest differentiation (Pinco et al., l993; Henion et al.,
l995), although the receptors that mediate these activities
have not been fully characterized. To examine whether
ectopic expression and activation of trkC was capable of
inducing neural differentiation, the relative percentages of
neurofilament positive, virally infected cells, were deter-
mined 48 h after cells were plated. This relatively short
culture period resulted in low numbers of neurons, but
minimized the potential complication of the survival ef-
fects of neurotrophins on crest-derived neurons (Wright et
al., l992). In the absence of NT-3, there were no significant
differences in neuronal numbers in any of the infected
cultures (data not shown), nor were there any differences
between the percentages of neurons that differentiated in
the control virus-infected cells in the presence or absence of
NT-3 (1.25% vs 1.37%, mean of two separate experiments,
quadruplicate wells). As shown in Fig. 4B, in the presence of
NT-3, the percentage of cells that differentiated into neu-
rons in the cultures infected with TK1 virus was nearly
2.5-fold greater than that in either control virus-infected or
uninfected cultures (P # 0.0001). Counts of GAG1/NF1
cells confirmed that 125/126 neurons were indeed infected.
In addition to the classical, NF1 neuronal morphology,
another population of cells was observed in all treatments
that was flat, lamellar, and nonpolar in shape with short
neurites. Because these cells were also NF1, we refer to
these cells as proneurons and their number was also signifi-
cantly increased in cultures expressing TK1 receptors.
Surprisingly, we found that the cultures containing the
greatest percentage of neurons and proneurons were those
expressing TK2 receptors. TK2-infected cultures con-
tained 3.5 to 4 times the percentage of neurons (P # 0.0001)
and proneurons as in control cultures and significantly
more neurons than the TK1 wells (Fig. 4B; P # 0.05). These
results were observed in a total of 16 separate experiments
and demonstrate that the kinase-minus isoform of trkC is
capable of promoting neural differentiation.
Truncated trk receptors have the capacity to alter cellular
activity by heterodimerizing with, and thereby inactivat-
ing, full-length tyrosine kinase-containing receptors (Eide
et al., l996). Our immunocytochemical studies demon-
strated the lack of cell surface expression of any endog-
enously expressed trkC receptors (Fig. 3) and hence are
FIG. 3. Immunolabeling with the anti-trkC IgG on live, nonper-
meabilized cells reveals no endogenous expression of trkC in
control virus-infected cells. Cells infected either with the control
virus (A), the TK1 virus (B), or TK2 virus (C) were incubated with
the CTC IgG at 4°C for 1 h as described under Methods. All
photographic exposures were of equal duration to compare inten-
sity levels. Staining live, nonpermeabilized cells reveals that ec-
topic expression of trkC is on the surface and that control virus-
infected cells express no endogenous trkC on their surface (scale
bar, 50 mm). Note how overexpression of the TK2 receptor alters
cell morphology; overexpression of the trkB TK2 receptor has also
been observed to alter cell morphology (Haapasalo et al., l997).
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FIG. 4. (A) Expression and activation of trkC TK2 promotes neural crest proliferation. Neural crest cells were either uninfected or infected
with control, TK1, or TK2 viruses and total cell number determined both 2 and 48 h after plating. Viruses were added at the time of plating,
and NT-3 (40 ng/ml) was added 24 h after plating. Each experiment was conducted in quadruplicate. Values represent the mean change in
cell number for each treatment (number of cells at t 5 48 h minus number of cells at t 5 2 h ) relative to the change in number of control
virus-infected cells over the same period, plus SEM from three separate experiments. ANOVA and Student–Newman–Keuls Method; P #
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inconsistent with a dominant negative mechanism under-
lying the TK2-induced neural differentiation. To further
examine this question, we engineered and expressed a novel
receptor construct that contained the entire extracellular
and transmembrane domain of trkC, but replaced the con-
served cytoplasmic domain of the truncated trkC receptor
with an epitope tag (Cyto2; Fig. 1). We verified that both
the TK2 and Cyto2 receptors could significantly suppress
TK1 tyrosine autophosphorylation in chick embryo fibro-
blasts and hence could function in a dominant negative
manner (see Discussion; and Boeshore and Large, unpub-
lished). As shown in Fig. 4C, cultures expressing the Cyto2
receptor did not contain a significantly greater percentage of
neurons than control cultures arguing against a mechanism
involving a “dominant negative” effect on TK1 receptor
signaling. The failure of the trkC KT isoform to promote
neural differentiation (data not shown) is also consistent
with this interpretation and suggests that the conserved
cytoplasmic tail specific to the TK2 receptor is required for
stimulating neural differentiation.
Since no data exist that explain mechanisms for how the
trkC TK2 receptor might function, we tested whether
receptor dimerization was sufficient. Previous studies have
demonstrated that neuronal survival, in the absence of
neurotrophins, can be promoted by incubation with poly-
clonal bivalent antibodies directed against the extracellular
domain of trk receptors (Clary et al., l994; Lefcort et al.,
l996). Activation of the TK1 isoform with 10 mg/ml of
bivalent trkC IgG (CTC IgG) mimicked the effect of NT-3
(Fig. 4D), resulting in a 22% increase in TK1 cells relative
to control virus-infected cells (P # 0.0001). Conversely,
NT-3 or trkC IgG treatment of cultures expressing TK2 and
Cyto2 receptors had no significant effect on cell prolifera-
tion (Fig. 4D). Although a higher concentration of CTC IgG
(100 mg/ml) was required to stimulate neural differentiation
for TK1-infected cells (Fig. 4E), the bivalent antibody was
unable to promote neural differentiation in the TK2 and
Cyto2-infected cells. Analysis of phosphotyrosine levels on
trkC2TK1 immunoprecipitated from CEF cells confirmed
a higher level of autophosphorylation after stimulation
with 100 versus 10 mg/ml of CTC IgG (data not shown).
These data indicate that low levels of TK1 receptor activa-
tion are sufficient for promoting proliferation, yet higher
levels of TK1 receptor stimulation are required for neural
differentiation (cf. Verdi and Anderson, l994; Lillien, l995).
Furthermore, there appear to be at least two distinct recep-
tor pathways that can promote neural differentiation: one
pathway stimulated by dimerization and hence activation
of the TK1 receptor and a second pathway mediated by the
TK2 receptor, in which its dimerization is insufficient for
activation.
The results for the TK2 receptor could be explained by
the involvement of an additional receptor capable of inter-
acting with NT-3. One candidate, the common neurotro-
phin receptor, p75NTR, has been identified on avian neural
crest cells (Bernd, l985; Heuer et al., l990; Rifkin and
Lefcort, unpublished observation). RCAS(BP)-infected neu-
ral crest cells were immunolabeled in vitro with an anti-
0.0001). (B) Expression and activation of either trkC TK2 or trkC TK2 induces neural differentiation. Numbers represent mean percentage
of cells that were neurons or proneurons, plus SEM, from quadruplicate cultures from three separate experiments. Cells were cultured for
48 h total, as above (A). ANOVA and Student–Newman–Keuls method of analyses demonstrated that activation and expression of both the
TK1 and TK2 isoforms of trkC induces significantly more neurons and proneurons than in control virus-infected or uninfected cells (P #
0.0001). The TK2 isoform induces significantly more neurons and proneurons than the TK1 isoform (P # 0.05). (C) Expression of the
cytoplasmic tail of the trkC TK2 isoform is required for TK2-induced neural differentiation. Numbers represent the mean percentage of
neurons which differentiated after 48 h in culture and are the results of quadruplicate cultures from three separate experiments. There are
not significantly more neurons in the Cyto2-infected wells than control virus-infected wells. Rather, activation of TK2 isoform promotes
significantly more neural differentiation than both the control and Cyto2 isoform. Analyses as above, P # 0.003. (D) Dimerization of trkC
TK1 by the anti-trkC IgG is sufficient to promote proliferation. Numbers represent the change in cell number, relative to control
virus-infected cells, between the time of plating and fixation (48 h). Activation of only the TK1 isoform of trkC by either NT-3 or CTC IgG
causes a net increase in cell number (P # 0.0001). (E) A higher level of TK1 activation is required for neural differentiation than for
proliferation while receptor dimerization is insufficient for TK2-induced neural differentiation. Neural crest cells were infected with
control, TK1, TK2, or Cyto2 viruses and cultured in the presence of CTC IgG at either 10 or 100 mg/ml and neuronal numbers were
determined after 48 h. While CTC IgG at 10 mg/ml was incapable of inducing TK1-induced neural differentiation, CTC IgG at 100 mg/ml
could promote TK1-induced neural differentiation (ANOVA, P # 0.014) while still being insufficient for the promotion of TK2-induced
neural differentiation.
TABLE 1
Proliferation Rate (Labeling Index) for Virus-Infected Cultured
Neural Crest Cells
Virus treatment Labeling index
Control (no NT-3) 43.8%
Control (NT-3, 40 ng/ml) 42.1
trkC-TK1 (NT-3, 40 ng/ml) 54.9*
trkC-TK2 (NT-3,40 ng/ml) 46.7
Cyto2 (NT-3,40 ng/ml) 42.3
* ANOVA, P # 0.025. The proliferation rate for TK1-infected
cells was significantly greater than that for control virus or Cyto2
infected cells (Student–Newman–Keuls, P # 0.05).
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body to p75NTR (CHEX; Weskamp and Reichardt, l991) to
determine the number of p75NTR1/NF1 and NF2 cells. We
found that all neurons and proneurons were p75NTR1
(145/145 neurons; 73/73 proneurons) and that in each well
approximately 60% of the cells expressed p75NTR. We then
tested the requirement of p75NTR in the neurogenic re-
sponse induced by the ectopically expressed TK2 receptor
and found that antibodies to p75NTR completely blocked
TK2-induced neural differentiation (Fig. 5) but had no
affect on TK1-induced neural differentiation (2.2 6 0.3% in
the absence of CHEX vs 2.1 6 0.2% in the presence of 100
mg/ml CHEX IgG). These data indicate that p75NTR collabo-
rates with the trkC TK2 receptor to stimulate the neuro-
genic response.
DISCUSSION
Our studies are the first to identify a behavioral response
to activation of the tyrosine kinase-deleted, truncated iso-
form of the trkC receptor. Furthermore, they show that
while neural differentiation can be induced by activation of
either the full-length kinase-containing receptor (TK1) or
the truncated receptor (TK2), the underlying mechanisms
differ considerably. Only in the case of the TK1 receptor is
dimerization of the receptor sufficient to elicit neural
differentiation. In contrast, neural differentiation induced
by activation of the truncated receptor requires the partici-
pation of p75NTR. Not only can activation of the TK1
receptor induce neural differentiation, but also cell prolif-
eration, whereas activation of the truncated receptor has no
mitogenic affect. These results indicate that two very
different behavioral repertoires can be elicited by two
distinct isoforms of the same receptor and demonstrate the
potentially signficant role truncated tyrosine kinase recep-
tors could play in developing systems. If each receptor
isoform can influence a discrete behavior, then expression
of multiple receptor isoforms may provide a cell with an
effective mechanism to modulate its response to environ-
mental signals.
All three relevant receptors described here, the truncated
TK2 isoform, the TK1 isoform, and p75NTR, are expressed
in the developing peripheral nervous system (cf. Davies,
l994). By RT–PCR, we have demonstrated that mRNAs for
both trkC receptor isoforms are present in the immature
chick DRG in ovo at an age (E4.5) corresponding to the peak
period of neurogenesis (data not shown; Carr and Simpson,
l978; Pannesi, l974). We have also shown that p75NTR
protein is widely expressed on both dividing precursor cells
and nascent neurons in the immature chick DRG (Rifkin et
al., l996; Rifkin and Lefcort, unpublished observations).
Using our antibody directed against the extracellular do-
main of trkC (CTC IgG), we have shown that individual
cells (including a subset of dividing precursor cells) in the
nascent DRG (E4.5) coexpress both trkC protein and
p75NTR protein, although we can not determine the iden-
tity of the trkC receptor isoform with this antibody. Fur-
thermore, using the CTC IgG, we have demonstrated that
ca. 5% of migrating chick trunk neural crest cells in vivo
express trkC protein and the vast majority of them express
p75NTR (Rifkin et al., l996; Rifkin and Lefcort, unpublished
observations). Interestingly, Henion et al. (l995) have
shown that only the trkC mRNA-expressing subpopulation
of neural crest cells have neurogenic potential in vitro. Not
only is it now important to determine whether a single cell
in the neural crest or DRG at any stage of its development
coexpresses both receptor isoforms, but also to elucidate
the mechanisms leading from trkC activation to neuronal
differentiation.
The biological function and significance of truncated
tyrosine kinase receptors has been a topic of considerable
interest since their discovery. Based on their structure, they
have been proposed to act as modulators of the full-length,
tyrosine kinase-containing receptors by potentially het-
erodimerizing with them and acting as “dominant nega-
tives” or perhaps by sequestering neurotrophin and thereby
regulating the amount of neurotrophin available to the
TK1 receptor isoforms (cf. Bothwell, l995). Given their lack
of a tyrosine kinase domain, they have not been thought to
transduce any signals by themselves. Strikingly though,
their alternative cytoplasmic domains are extremely well
conserved through evolution: 36/39 amino acids of the trkC
alternative cytoplasmic domain are entirely conserved be-
tween chicken and mammals (see Garner and Large, l994)
and the conservation between the truncated alternative
trkB cytoplasmic domains is also maintained across species
FIG. 5. Blockade of p75 inhibits neural differentiation induced by
activation of the TK2 receptor. Numbers represent mean percent-
age of neurons which differentiated in cultures of neural crest cells
after 2 days in vitro (of 300–500 cells counted total/well). Cells
were infected with viruses (Control or trkC TK2) immediately
after plating and incubated with 20–40 ng/ml NT-3. In addition,
some wells received the anti-p75NTR antibody, CHEX (100 mg/ml;
gift of Dr. L. F. Reichardt) or control rabbit IgG (Cappel, 100 mg/ml).
Mean and SEM of quadruplicate wells from two separate experi-
ments. *P # 0.05.
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(Armanini et al., l995; Biffo et al., l995). Recent evidence
indicates that TK2 isoforms of the trkB receptor can
stimulate cytoplasmic signal transduction using an as yet
unknown mechanism (Baxter et al., l997). Furthermore,
Tessarollo and his colleagues have shown that targeted
deletion of the entire gene for trkC results in mice with a
more severe phenotype in both the nervous system and
other tissues than mice in which just the TK1 isoform has
been deleted (Donovan et al., l996; Liebl et al., l997;
Tessarollo et al., l997). Recently they have shown that
transgenic mice overexpressing the truncated trkC receptor
exhibit severe defects in their nervous systems (L. Tessa-
rollo, personal communication).
In our study, we do not believe that the TK2 receptor is
inducing neural differentiation by modifying signaling
through any endogenously expressed TK1 trkC receptor.
Not only do we see no expression of any endogenous trkC
in nonpermeabilized, live cells using an antibody directed
against the extracellular domain of the receptor, but also
neither the KT isoform of the receptor nor the Cyto2
construct was able to induce neural differentiation in the
same neural crest cell cultures. Furthermore, we have
verified that the Cyto2 construct and the TK2 receptor
were equivalent in their ability to act as dominant nega-
tives by coexpressing each isoform with the TK1 receptor
in an approximately 1:1 ratio in chick fibroblasts, and the
extent of tyrosine phosphorylation on the TK1 isoform was
determined. We found that both receptors, either the TK2
or Cyto2, were able to decrease the amount of TK1
tyrosine phosphorylation to the same extent and with the
same time course (when coexpressed with TK2 receptor,
TK1 phosporylation was reduced by 83 6 6.5%; when
coexpressed with Cyto2 receptor construct, TK1 phos-
phorylation was reduced by 78 6 4%, Boeshore and Large,
unpublished observations). Thus the capacity of the TK2
isoform to induce neural differentiation cannot simply be
due to a potential “dominant negative” activity.
How might activation of the truncated trkC receptor alter
cell behavior? The trkC TK2 isoform contains the jux-
tamembrane KFG motif necessary for activation of SNT/
FRS2 (Peng et al., l995; Kouhara et al., l997), a cytoplasmic
adapter protein involved in neurotrophin-stimulated differ-
entiation. However, the inability of the KT isoform which
also contains the KFG motif to stimulate differentiation
suggests that the critical signaling motif resides in the
highly evolutionarily conserved 39 amino acid C-terminal
domain (Garner and Large, l994). This domain contains a
tyrosine residue, although it is not phosphorylated in re-
sponse to NT-3 (Boeshore and Large, unpublished observa-
tions). The inability of the trkC extracellular antibodies
alone to stimulate differentiation and the blockade of
differentiation by the anti-p75NTR antibodies indicates the
response also requires the p75NTR receptor. Conceivably,
independent signaling through trkC TK- and p75NTR recep-
tors may combine to generate a differentiative signal. Al-
ternatively, trkC TK- receptor may heterodimerize with the
p75NTR receptor to activate signaling pathways leading to
differentiation, or modify p75NTR signaling such that cel-
lular responses are shifted from apoptosis (Dechant and
Barde, l997; Casaccia-Bonnefil et al., l996) to differentia-
tion.
Our data implicate both kinase-containing and kinase-
minus isoforms of trkC and p75NTR in the process of
peripheral neuronal differentiation. One pathway requires
only stimulation of the TK1 receptor, while the other
pathway requires the joint participation of the TK2 recep-
tor and p75NTR. Indeed, both TK1 and TK2 mRNA are
present in the immature (E4.5) DRG, which contains both
proliferating precursor cells and newly differentiated neu-
rons (data not shown; Carr and Simpson, l978). Hence, the
neuronal deficit observed in mice in which both the TK2
and TK1 isoforms of trkC are deleted (Liebl et al., l997;
Tessarollo et al., l997) might be due, in part, to the inability
of a subset of cells to differentiate. Similarly, it is conceiv-
able that in transgenic mice that overexpress the TK2
isoform, neural progenitor cells are prematurely driven out
of the cell cycle and differentiate, ultimately leading to a
net reduction in neuronal numbers (L. Tessarollo, personal
communication; Farinas et al., l996). In light of our data
implicating p75NTR in neurogenesis, it will be important to
determine if the neuronal deficit observed in DRG of
p75NTR knock-out mice is partially due to an inhibition of
neuronal differentiation.
The fact that only a small subset of neural crest cells were
driven toward a neuronal fate by overexpression of the TK2
receptor may speak not only to our culture conditions
(media and time course), but also to the heterogeneity of
neural crest cells and perhaps to the narrow temporal
window in which these differentiative decisions can be
modulated. Our data extend the range of activities in which
TK2 receptors may perform, from merely inhibiting TK1
receptors, or sequestering ligand, to promoting neural dif-
ferentiation, and identify a novel functional interaction of
this receptor with p75NTR. Thus, given that all three
receptors are expressed in the immature dorsal root gan-
glion during a period of active proliferation and differentia-
tion, the decision by a precursor cell to proliferate or
differentiate may be significantly regulated by the relative
expression levels and activation of the TK1 and TK2
isoforms of trkC and of p75NTR receptors.
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